SM
ARNA

SG3 Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

SG3 Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-47,100
Closed -$4.38M – 1502
2021
Q4 		$4.38M Buy
+47,100
New +$3.1M 0.09% 202
2020
Q3 		– Sell
-18,500
Closed -$1.23M – 1125
2020
Q2 		$1.17M Buy
+18,500
New +$1.02M 0.08% 268

SG3 Management's ARNA Position: Q1 2022 in Review

SG3 Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 47,100 shares — an estimated $4.38M sold.

SG3 Management first reported a position in ARNA in Q2 2020 and held it in 2 quarters. The position peaked at $4.38M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • SG3 Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • SG3 Management sold 47,100 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $4.38M.
  • SG3 Management first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 2 quarters.
  • SG3 Management's Arena Pharmaceuticals Inc position peaked at $4.38M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on SG3 Management's 13F filing for Q1 2022, filed 16 May 2022.